November 29, 2016 - By Peter Kolinski
Senior Vice President Hobart Kalkstein of Cabot Corp, unloaded 4,890 of the Pinksheet-listed Cabot Corp shares having an approx. value of $253,302 USD with an average of $51.8 price for each share. Mr. Hobart at present possess 29,739 shares, accounting for 0.05% of Cabot Corp’s market cap.
Out of 6 analysts covering Cabot (NYSE:CBT), 2 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 33% are positive. $55 is the highest target while $37.0 is the lowest. The $52.25 average target is 3.14% above today’s ($50.66) stock price. Cabot has been the topic of 9 analyst reports since August 13, 2015 according to StockzIntelligence Inc. The stock has “Hold” rating given by Deutsche Bank on Friday, August 12. The firm has “Buy” rating by BB&T Capital given on Thursday, December 10. The stock of Cabot Corp (NYSE:CBT) earned “Neutral” rating by SunTrust on Tuesday, August 2. The stock of Cabot Corp (NYSE:CBT) has “Sell” rating given on Tuesday, September 1 by Zacks. The firm has “Sector Weight” rating by KeyBanc Capital Markets given on Monday, April 11. The rating was maintained by Deutsche Bank on Wednesday, November 11 with “Buy”. The stock has “Neutral” rating given by JP Morgan on Monday, March 14. The firm has “Hold” rating by Deutsche Bank given on Thursday, August 13.
Insitutional Activity: The institutional sentiment decreased to 0.94 in 2016 Q2. Its down 0.15, from 1.09 in 2016Q1. The ratio dropped, as 24 funds sold all Cabot Corp shares owned while 84 reduced positions. 22 funds bought stakes while 96 increased positions. They now own 52.28 million shares or 0.87% less from 52.74 million shares in 2016Q1.
The Switzerland-based Swiss Bank & Trust has invested 0.01% in Cabot Corp (NYSE:CBT). Goldman Sachs Gru has invested 0% of its portfolio in Cabot Corp (NYSE:CBT). The New York-based Springbok Ltd Liability has invested 0.03% in Cabot Corp (NYSE:CBT). Ubs Asset Mngmt Americas has 0% invested in the company for 61,209 shares. Dupont Capital Mngmt last reported 0.04% of its portfolio in the stock. Mufg Americas Hldgs has 0.01% invested in the company for 4,500 shares. Gemmer Asset Lc has 172 shares for 0% of their US portfolio. Macquarie Grp owns 26,400 shares or 0% of their US portfolio. National Bank Of Montreal Can holds 0% or 3,242 shares in its portfolio. Amp Investors holds 0.01% of its portfolio in Cabot Corp (NYSE:CBT) for 48,590 shares. Bnp Paribas Arbitrage holds 0.01% of its portfolio in Cabot Corp (NYSE:CBT) for 25,574 shares. Strategic Global Advsrs Ltd Liability Company has invested 0.2% of its portfolio in Cabot Corp (NYSE:CBT). Omers Administration Corp reported 31,900 shares or 0.03% of all its holdings. Lpl Fin Limited Liability Company last reported 0% of its portfolio in the stock. Glenmede Tru Com Na owns 4,115 shares or 0% of their US portfolio.
Insider Transactions: Since July 12, 2016, the stock had 0 insider purchases, and 11 sales for $12.39 million net activity. Shares for $127,375 were sold by Kelly James Patrick on Thursday, July 28. Prevost Patrick M. sold $110,468 worth of stock. 16,489 shares were sold by BERUBE BRIAN A, worth $822,765. On Friday, November 11 the insider von Gottberg Friedrich sold $998,181. 21,584 shares were sold by Cross Nicholas S., worth $1.09M on Monday, August 29. Shares for $1.35 million were sold by CORDEIRO EDUARDO E on Tuesday, August 23.
About 440,615 shares traded hands or 20.45% up from the average. Cabot Corp (NYSE:CBT) has risen 3.52% since April 26, 2016 and is uptrending. It has underperformed by 1.74% the S&P500.
Cabot Corporation is a global specialty chemicals and performance materials company. The company has a market cap of $3.13 billion. The Company’s principal products are rubber and specialty grade carbon blacks, fumed metal oxides, activated carbon, inkjet colorants, aerogel and cesium formate drilling fluids. It has a 21.53 P/E ratio. The Firm operates through four divisions: Reinforcement Materials, Performance Chemicals, Purification Solutions and Specialty Fluids.
According to Zacks Investment Research, “Cabot Corporation is a global specialty chemicals and materials company. Cabot’s major products are carbon black, fumed silica, inkjet colorants, and aerogels. Cabot has manufacturing plants located in countries around the world. (Company Press Release)”
Analysts await Cabot Corp (NYSE:CBT) to report earnings on February, 6. They expect $0.69 EPS, up 35.29% or $0.18 from last year’s $0.51 per share. CBT’s profit will be $42.63 million for 18.36 P/E if the $0.69 EPS becomes a reality. After $1.00 actual EPS reported by Cabot Corp for the previous quarter, Wall Street now forecasts -31.00% negative EPS growth.
Another recent and important Cabot Corp (NYSE:CBT) news was published by Zacks.com which published an article titled: “Cabot Corp. (CBT): Stock Poised to Beat Earnings in Q4?” on October 28, 2016.
Cabot Corporation (Cabot), incorporated on July 14, 1960, is a global specialty chemicals and performance materials company. The Company’s principal products are rubber and specialty grade carbon blacks, fumed metal oxides, activated carbon, inkjet colorants, aerogel and cesium formate drilling fluids. The Firm operates through four divisions: Reinforcement Materials, Performance Chemicals, Purification Solutions and Specialty Fluids. It operates in three geographic regions: Americas Region; Europe, the Middle East and Africa (EMEA) Region, and Asia Pacific Region. Cabot and its affiliates have manufacturing facilities and activities in the United States and over 20 other countries. It focuses on creating particles with the composition, morphology, surface functionalities and formulations.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.